PWMG
SLS icon

Private Wealth Management Group’s SELLAS Life Sciences SLS Stock Holding History

Private Wealth Management Group’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,000
Closed -$42.3K – 1507
2026
Q1 		$42.3K Hold
10,000
– – 0.01% 212
2025
Q4 		$37.7K Hold
10,000
– – 0.01% 219
2025
Q3 		$16.1K Hold
10,000
– – ﹤0.01% 389
2025
Q2 		$21.9K Hold
10,000
– – 0.01% 282
2025
Q1 		$10.8K Buy
+10,000
New +$11.9K ﹤0.01% 443

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Private Wealth Management Group's SLS Position: Q2 2026 in Review

Private Wealth Management Group sold out of SELLAS Life Sciences (SLS) in Q2 2026, closing a stake of 10,000 shares — an estimated $42.3K sold.

Private Wealth Management Group first reported a position in SLS in Q1 2025 and held it in 5 quarters. The position peaked at $42.3K in Q1 2026. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Private Wealth Management Group reported no remaining SELLAS Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Private Wealth Management Group sold 10,000 SELLAS Life Sciences shares in Q2 2026, an estimated $42.3K.
  • Private Wealth Management Group first reported a position in SELLAS Life Sciences in Q1 2025 and held it in 5 quarters.
  • Private Wealth Management Group's SELLAS Life Sciences position peaked at $42.3K in Q1 2026.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Private Wealth Management Group's 13F filing for Q2 2026, filed 27 Jul 2026.